story of the week
Discontinuation of Disease-Modifying Therapy in Patients With Multiple Sclerosis Over Age 60
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Discontinuation of Disease-Modifying Therapy in Patients With Multiple Sclerosis Over Age 60
Mult. Scler. 2018 Mar 20;[EPub Ahead of Print], LH Hua, TH Fan, D Conway, N Thompson, TG KinzyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.